Author Question: The nature of employer liability changed in the 19th century through judicial instrumentalism and ... (Read 58 times)

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
The nature of employer liability changed in the 19th century through judicial instrumentalism and had what effect?
 
  (a) Reducing the risks and the costs of business, making business enterprise more daring and profitable than it would have been otherwise.
  (b) Increasing the risks and the costs of business, making business enterprise more daring and profitable than it would otherwise have been.
  (c) Continuing the older doctrine that employers could be found guilty of contributory negligence, thus increasing the employer's liability for worker injury.
  (d) None of the above were effects of the changes to the nature of employer liability.

Question 2

The federal funds market is the market for
 
  a. loans from the federal government.
  b. loans from the Federal Reserve.
  c. government borrowing and lending.
  d. interbank lending.
  e. all of the above.



alexisweber49

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

(a)

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library